Header

UZH-Logo

Maintenance Infos

Atovaquone/proguanil for malaria chemoprophylaxis - Could a difference in susceptibility during hepatic development explain the need to continue drug intake for 7 days post-exposure?


Hanscheid, Thomas; Schlagenhauf, Patricia; Grobusch, Martin P (2020). Atovaquone/proguanil for malaria chemoprophylaxis - Could a difference in susceptibility during hepatic development explain the need to continue drug intake for 7 days post-exposure? Travel Medicine and Infectious Disease, 33:101527.

Statistics

Citations

Dimensions.ai Metrics
1 citation in Web of Science®
1 citation in Scopus®
Google Scholar™

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Epidemiology, Biostatistics and Prevention Institute (EBPI)
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Public Health, Environmental and Occupational Health
Health Sciences > Infectious Diseases
Language:English
Date:1 January 2020
Deposited On:18 Feb 2020 14:31
Last Modified:29 Jul 2020 14:37
Publisher:Elsevier
ISSN:1477-8939
OA Status:Closed
Publisher DOI:https://doi.org/10.1016/j.tmaid.2019.101527
PubMed ID:31759143

Download

Full text not available from this repository.
View at publisher

Get full-text in a library